Skip to main content
. 2023 Nov 29;136(24):2931–2937. doi: 10.1097/CM9.0000000000002939

Figure 1.

Figure 1

Serum lipid change 1 year after switching to TAF/FTC/BIC among subcategories receiving NNRTI-containing regimens at baseline. BIC: Bictegravir sodium; EFV: Efavirenz; FTC: Emtricitabine; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; NNRTI: Non-nucleotide reverse transcriptase inhibitor; NVP: Nevirapine; TAF: Tenofovir alafenamide; TC: Total cholesterol; TG: Triglyceride.